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Abstract
Background: Herein is sought to determine whether the occurrence of post-operative atrial fibrillation 
(POAF) increases the risk of late recurrence of atrial fibrillation (AF) in patients undergoing open heart 
surgery (OHS).
Methods: This study included 938 patients (56.7 ± 13.1 years old, 550 males) with no history of AF 
who underwent OHS. All patients were monitored continuously for development of POAF after surgery 
until the time of hospital discharge and received clinical follow up with serial evaluation of rhythm 
status. 
Results: Among the total population, POAF occurred in 207 (22.1%) patients and late AF in 88 
(9.4%) patients during the mean follow up period of 78.1 ± 39.1 months. Development of late AF oc-
curred more frequently in patients with POAF than in those without [29.0% (60/207) vs. 3.8% (28/731), 
p < 0.01]. Higher septal E/e’ ratio (HR 1.04, 95% CI 1.00–1.08, p = 0.04) was an independent predic-
tor of late occurrence of AF and an episode of POAF (HR 27.12, 95% CI 8.46–86.96, p < 0.01) was 
the most powerful predictor. 
Conclusions: POAF is significantly associated with an increased risk of late AF recurrence during 
long-term follow up. Careful concern regarding late recurrence of AF with serial evaluation of rhythm 
status is required in patients with POAF. (Cardiol J 2017; 24, 6: 633–641)
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Introduction
Post-operative atrial fibrillation (POAF) is 
a frequent complication affecting 20–40% of patients 
following open heart surgery (OHS). POAF after 
cardiac surgery is usually self-limiting [1], and 
most patients are in sinus rhythm at discharge. 
However, POAF can sometimes result in increased 
risk of post-operative stroke, morbidity, and pro-
longed hospitalization [2–4]. Recent studies have 
suggested that POAF following coronary artery 
bypass surgery (CABG) carries a risk of future 
atrial fibrillation (AF) recurrence and higher mor-
tality than patients without an episode of POAF 
[5, 6]. However, late occurrence rate of AF during 
long-term follow up in patients receiving overall 
OHS has yet to be determined.
This study investigated the relationships 
between POAF and late occurrence of AF during 
long-term follow up in a large cohort of patients 
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who underwent OHS. It was hypothesized that 
POAF is a risk factor for late occurrence of AF. 
Methods
Patients 
This retrospective study included 938 adult 
patients (56.7 ± 13.1 years old, 550 males) with no 
prior history of AF among 1483 patients who un-
derwent OHS between January 1999 and June 2010. 
Exclusion criteria were: 1) patients who had previ-
ously documented AF before surgery (n = 260), 
2) patients with another form of significant ar-
rhythmia which might affect the occurrence of 
AF such as sinus node dysfunction (n = 5), 3) pa-
tients who had undergone permanent pacemaker 
implantation prior to surgery (n = 5), 4) patients 
who had undergone OHS previously (n = 73) and 
4) patients who did not receive clinical follow up for 
more than 1 year (n = 202). All patients were fol-
lowed up regularly in the outpatient clinic. Finally, 
938 patients were enrolled in this study and were 
divided into two groups based on the development 
of POAF (POAF group; n = 207, and no POAF 
group; n = 731). 
Clinical characteristics including demograph-
ics, cardiovascular risk factors, laboratory data, 
peri/post-operative information, and clinical out-
comes were obtained through chart review. Hy-
pertension was defined as systolic blood pressure 
≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg, 
or if they were already being treated for this con-
dition. Diabetes mellitus was defined as fasting 
glucose ≥ 126 mg/dL or 2 h post-prandial glucose 
≥ 200 mg/dL or glycated hemoglobin (HbA1c) 
≥ 6.5%, or if they were already being treated for 
this condition. Renal dysfunction was defined as 
serum creatinine elevation above 1.2 mg/dL with 
or without the need for hemodialysis. The elevation 
of creatinine value was confirmed with more than 
one determination before surgery. For diagnosis of 
dyslipidemia, triglyceride (≥ 150 mg/dL) and high 
density lipoprotein-cholesterol (HDL-C) levels 
(< 40 mg/dL for males and < 50 mg/dL for females) 
were used as parameters [7]. High sensitivity 
C-reactive protein (hsCRP) levels were deter-
mined using a turbidimetic assay (Denka Seiken, 
Tokyo, Japan) using the Hitachi 7600-110. Labora-
tory tests were repeated within 48 h after the op-
eration. Diagnosis of post-operative infection was 
established if at least one of the following criteria 
were present: 1) positive blood, urine or surgical 
wound discharge cultures, 2) pyrexia > 38°C for 
at least 2 days beyond the first 2 post-operative 
days, associated with white cell count elevation, 
3) radiologic indication of significant lung consoli-
dation, and 4) clinical signs of significant surgical 
wound infection [8].
The local Institutional Review Board approved 
this study and all patients provided written in-
formed consent. 
Evaluation of rhythm status
All patients were treated with beta-blocker 
at least 7 days before the operation, unless con-
traindicated. Prophylactic anti-arrhythmic drugs 
were not administered. Patients were continu-
ously monitored by bedside electrocardiogram 
(ECG) monitoring of lead II for the first 48 h after 
surgery. After transferring to general wards, the 
arrhythmias were detected by regular 4-h clinical 
assessment and a standard 12-lead ECG which was 
routinely performed every day until discharge. 
Continuous ECG monitoring or Holter monitoring 
was reinstituted if patients complained of symp-
toms suggesting arrhythmia during hospitaliza-
tion. POAF was defined as a newly developed AF 
episode lasting more than 1 min documented by 
12-lead ECG or continuous monitoring during the 
first 1 month after surgery and late occurrence of 
AF was defined as occurrence of AF after 1 month. 
Onset, duration of AF, management of AF, and 
rhythm status at discharge were reviewed in the 
patient’s record. 
Echocardiographic measurements 
Echocardiographic measurements were ob-
tained before the operation in all patients. The 
2-dimensional and M-mode echocardiograms were 
obtained according to the recommendation of 
the American Society of Echocardiography, with 
patients in the left lateral decubitus position [9]. 
Left atrial (LA) dimensions were measured using 
the parasternal long-axis and apical 4-chamber 
views at ventricular end systole (maximum LA 
size). The left ventricular (LV) end-diastolic and 
end-systolic dimensions were measured using 
M-mode echocardiography recorded from the 
para-sternal long axis view. The LV end-diastolic, 
end-systolic volumes and ejection fraction (EF) 
were measured by the modified bi-plane Simpson 
rule [10]. Diastolic function was determined based 
on Doppler echocardiography and evaluated by 
the analysis of peak trans-mitral inflow velocities 
(E: early diastolic mitral flow velocity, A: late dia-
stolic mitral flow velocity). The deceleration time 
of the E waves was also measured. Peak velocities 
during early (E’) and late (A’) diastole at the level 
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of the septal mitral annulus were measured using 
pulsed-wave tissue Doppler. Thereafter, E/A and 
E/e’ ratios reflecting LV end-diastolic pressure 
were calculated. At least three cardiac cycles were 
averaged for each parameter measurement.
Type of OHS
The type of surgery was classified as isolated 
CABG, valve surgery, aorta surgery, or combined sur-
gery. Off-pump coronary bypass surgery (OPCAB) 
was performed in selected patients at the dis-
cretion of the physician. Heart transplantation 
(n = 4), mass excision (n = 20), and surgery for 
congenital heart disease (n = 57) were classified 
as miscellaneous. 
Management of POAF
All patients with POAF were managed with 
rate control drugs including beta-blockers, unless 
contraindicated, and anticoagulation was admin-
istered in patients with continuous AF more than 
48 h after the onset of POAF. Highly symptomatic 
patients or patients with failure of medications in 
controlling the ventricular rate led to cardiover-
sion using anti-arrhythmic drugs or by electrical 
cardioversion at the suggestion of a previous study 
stating that a primary rate-control strategy may be 
equivalent to a strategy that restores sinus rhythm 
[11]. Patients who were discharged to their homes 
in AF rhythm were maintained on warfarin (in the 
absence of any contra-indication) and were usually 
referred for cardioversion after 3–6 weeks. In the 
absence of evidence of AF recurrence 3 months 
subsequent to the operation, anti-arrhythmic drugs 
were usually stopped at the discretion of the physi-
cian. If patients  remained in AF, other medications 
were added or cardioversion was considered. 
Clinical follow up 
The patients were seen in an outpatient clinic 
at 1 week and then 1, 3, 6, 9, and 12 months after 
discharge, subsequently every 3 or 6 months 
thereafter. A 12-lead surface ECG was performed 
at every visit. A detailed history of the patients’ 
symptoms suggesting potential for arrhythmia 
occurrence was taken and 24-h or 48-h Holter 
monitoring was performed in those patients. All 
patients received clinical follow up with serial 
evaluation of rhythm status for more than 1 year. 
Statistical analysis
Patients were classified according to two 
groups and those who did not develop POAF 
served as the control group. Continuous variables 
are reported as mean ± standard deviation, while 
categorical variables are reported as a number or 
percentage. Student t test was used for compari-
son of continuous variables, while categorical vari-
ables were compared using c2 test or the Fisher 
exact test, as appropriate among groups. AF free 
survival (any occurrence of atrial arrhythmia) was 
estimated using the Kaplan-Meier method and 
AF free survival was compared between POAF 
group and without POAF group using a Wilcoxon 
log rank test. Multivariate analysis was performed 
for analysis of the independent predictors of 
late occurrence of AF. Univariate variables with 
p < 0.05 were entered into the model (control for 
confounding). All tests were 2-tailed and a p-value 
of < 0.05 was considered significant. All statisti-
cal analyses were performed using SPSS 12.0 
software (SPSS, Inc., an IBM Company, Chicago, 
Illinois, USA). 
Results
Baseline characteristics according  
to the POAF
Among the total population, 207 (22.1%) pa-
tients developed POAF. Baseline characteristics 
according to development of POAF are compared 
in Table 1. Patients with POAF were significantly 
older than those without (60.4 ± 11.2 vs. 55.7 ± 
± 13.5 year, p < 0.01). Patients with POAF showed 
significantly higher hsCRP level (11.8 ± 6.2 vs. 
10.3 ± 7.2 mg/dL, p = 0.04) after the operation. LA 
diameter (42.4 ± 8.4 vs. 40.7 ± 6.7 mm, p = 0.02) 
and LA volume (71.4 ± 39.0 vs. 63.0 ± 33.3 mL, 
p = 0.04) were significantly larger in patients with 
POAF than those without. E/e’ was significantly 
higher in patients with POAF (16.9 ± 11.8 vs. 
14.7 ± 7.8, p = 0.04). Other echocardiographic 
measurements including LVEF were similar be-
tween the two groups. The incidence of POAF dif-
fered significantly according to the type of surgery, 
with the highest frequency in patients undergoing 
combined aorta and valvular surgery (34.4%) fol-
lowed by isolated valvular surgery (33.0%). The 
POAF group included significantly fewer patients 
who underwent OPCAB than the no POAF group 
(19.3% [40/207] vs. 32.3% [236/731], p < 0.01). 
A significantly higher proportion of patients with 
POAF underwent mitral valvular surgery (21.2% 
[44/207] vs. 10.3% [75/731], p < 0.01). Post-oper-
ative infection rate was similar between the two 
groups. Otherwise, clinical characteristics and the 
presence of co-morbidities were similar between 
the two groups. 
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Development of POAF occurred after mean 
3.77 ± 4.62 post-operative days. Of the 207 pa-
tients with POAF, 41 patients were treated with 
anti-arrhythmic drugs, 18 patients underwent 
electrical cardioversion in the immediate post-
operative period, 7 patients underwent scheduled 
electrical cardioversion after failure of converting 
to sinus rhythm with anti-arrhythmic drugs, and 
141 patients received only rate-control drugs dur-
ing hospitalization. A total of 6 patients remained 
in AF rhythm at discharge. 
A multivariable logistic regression was per-
formed for analysis of independent predictors of 
developing POAF. Older age showed borderline 
significance (OR 1.03, 95% CI 0.99–1.06, p = 0.06) 
and concomitant mitral valvular surgery was 
an independent predictor for developing POAF 
(OR 3.73, 95% CI 1.27–11.00, p = 0.02).
Late occurrence of atrial fibrillation  
during long-term follow up
Development of late AF occurred in 88 (9.4%) 
patients during the mean follow up period of 78.1 ± 
± 39.1 months. Baseline characteristics according 
to the development of late AF are compared in Table 2. 
Patients with late AF were significantly older 
than those without (61.6 ± 12.0 vs. 56.2 ± 13.2 
year, p < 0.01). Patients with occurrence of late 
Table 1. Patient characteristics according to development of post-operative atrial fibrillation (POAF).
POAF (+); n = 207 POAF (–); n = 731 P
Age [years] 60.4 ± 11.2 55.7 ± 13.5 < 0.01‡
Male 114 (55.1%) 436 (59.6%) 0.24
Hypertension 120 (58.0%) 379 (51.8%) 0.12
Diabetes mellitus 52 (25.1%) 202 (27.6%) 0.47
Dyslipidemia 93 (44.9%) 318 (43.5%) 0.72
CHF 40 (19.9%) 122 (17.6%) 0.45
CKD 30 (14.5%) 95 (13.0%) 0.58
Hemoglobin [g/dL] 11.0 ± 1.8 11.3 ± 1.8 0.05
Creatinine [mg/dL] 0.9 ± 0.5 0.9 ± 0.6 0.43
HbA1c [%] 7.1 ± 1.5 6.9 ± 1.5 0.68
NT-proBNP [pg/dL] 1107 ± 2464 1138 ± 3610 0.94
hsCRP [mg/dL] 1.7 ± 3.8 1.4 ± 2.6 0.26
Post-operative hsCRP [mg/dL] 11.8 ± 6.2 10.3 ± 7.2 0.04*
LA diameter [mm] 42.4 ± 8.4 40.7 ± 6.7 0.02*
LA volume [mL] 71.4 ± 39.0 63.0 ± 33.3 0.04*
E/A 1.08 ± 0.53 1.03 ± 0.62 0.36
E/E’ 16.9 ± 11.8 14.7 ± 7.8 0.04*
LVEF [%] 58.1 ± 12.4 58.3 ± 12.2 0.88
Type of surgery: < 0.01*
CABG 91 (44.0%) 408 (55.8%)
Valve surgery 72 (34.8%) 146 (20.0%)
Aorta surgery 19 (9.2%) 59 (8.1%)
Combined CABG and valve surgery 7 (3.4%) 21 (2.9%)
Combined CABG and aorta surgery 0 (0%) 2 (0.3%)
Combined valve and aorta surgery 11 (5.3%) 21 (2.9%)
Miscellanous 7 (3.4%) 74 (10.1%)
Off-pump operation 40 (19.3%) 236 (32.3%) < 0.01‡
Mitral valve surgery 44 (21.3%) 75 (10.3%) < 0.01*
Post-operative infection 7 (3.4%) 27 (3.7%) 0.82
*p < 0.05, ‡p < 0.01; CABG — coronary artery bypass graft; CHF — congestive heart failure; CKD — chronic kidney disease; HbA1c — glycated 
hemoglobin; hsCRP — high sensitivity C-reactive protein; LA — left atrial; LVEF — left ventricular ejection fraction; NT-proBNP — N-terminal 
pro-B-type natriuretic peptide
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AF showed higher incidence of congestive heart 
failure (25.9% [22/88] vs. 17.3% [140/850], p = 
= 0.05) and chronic kidney disease (21.6% 
[19/88] vs. 12.5% [106/850], p = 0.02) than those 
without late AF. Proportion of patients with 
hypertension, diabetes, dyslipidemia, coronary 
artery disease and male sex was similar between 
the two groups. Pre-operative and post-operative 
hsCRP levels were not significantly different 
between the two groups. LA volume was sig-
nificantly larger in patients with late AF than 
those without (80.3 ± 34.3 vs. 63.8 ± 34.7 mL, 
p = 0.01) and septal E/e’ ratio reflecting high LV 
end-diastolic pressure on the echocardiogram 
performed prior to surgery was significantly 
higher in patients with late AF (21.1 ± 15.3 
vs. 14.6 ± 7.9, p < 0.01). A significantly higher 
proportion of patients with late AF underwent 
mitral valvular surgery (22.7% [20/88] vs. 11.6% 
[99/850], p < 0.01).
Of patients who developed POAF, 147 (71.0%) 
remained in sinus rhythm during long-term follow 
up, however, development of late AF occurred 
more frequently in patients with POAF than in 
those without (29.0% [60/207] vs. 3.8% [28/731], 
p < 0.01) (Fig. 1).
Table 2. Patient characteristics according to development of late atrial fibrillation (AF).
Late AF (+); n = 88 Late AF (–); n = 850 P
Age [years] 61.6 ± 12.0 56.2 ± 13.2 < 0.01*
Male 51 (57.9%) 499 (58.7%) 0.89
Hypertension 46 (52.3%) 453 (53.3%) 0.86
Diabetes mellitus 26 (29.5%) 228 (26.8%) 0.58
Dyslipidemia 37 (42.0%) 374 (44.0%) 0.73
CHF 22 (25.9%) 140 (17.3%) 0.05*
CKD 19 (21.6%) 106 (12.5%) 0.02*
Hemoglobin [g/dL] 11.3 ± 1.7 11.3 ± 1.8 0.89
Creatinine [mg/dL] 1.0 ± 0.4 0.9 ± 0.6 0.38
HbA1c [%] 7.3 ± 1.6 6.9 ± 1.4 0.38
NT-proBNP [pg/dL] 1093 ± 1401 1134 ± 3490 0.95
hsCRP [mg/dL] 1.07 ± 1.55 1.47 ± 3.00 0.09
Post-operative hsCRP [mg/dL] 9.9 ± 5.4 10.7 ± 7.1 0.47
LA diameter [mm] 43.0 ± 9.5 40.9 ± 6.9 0.06
LA volume [mL] 80.3 ± 34.3 63.8 ± 34.7 0.01*
E/A 1.08 ± 0.56 1.04 ± 0.60 0.57
E/e’ 21.1 ± 15.3 14.6 ± 7.9 < 0.01‡
LVEF (%) 56.2 ± 12.6 58.4 ± 12.2 0.10
Type of surgery: < 0.01‡
CABG 35 (39.8%) 464 (54.6%)
Valve surgery 32 (36.4%) 186 (21.9%)
Aorta surgery 3 (3.4%) 75 (8.8%)
Combined CABG and valve surgery 5 (5.7%) 23 (2.7%)
Combined CABG and aorta surgery 0 (0%) 2 (0.2%)
Combined valve and aorta surgery 7 (8.0%) 25 (2.9%)
Miscellanous 6 (6.8%) 75 (8.8%)
Off-pump operation 25 (28.4%) 251 (29.4%) 0.83
Mitral valve surgery 20 (22.7%) 99 (11.6%) < 0.01‡
Post-operative infection 1 (1.1%) 33 (3.9%) 0.15
Post-operative AF 60 (68.2%) 147 (17.3%) < 0.01‡
*p < 0.05, ‡p < 0.01; CABG — coronary artery bypass graft; CHF — congestive heart failure; CKD — chronic kidney disease; HbA1c —  
glycated hemoglobin; hsCRP — high sensitivity C-reactive protein; LA — left atrial; LVEF — left ventricular ejection fraction; NT-proBNP —  
N-terminal pro-B-type natriuretic peptide
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Figure 1. Development of late atrial fibrillation (AF) oc-
curred more frequently in patients with post-operative 
atrial fibrillation (POAF) than in those without POAF 
[29.0% (60/207) vs. 3.8% (28/731), p < 0.01].
Figure 2. The Kaplan-Meier curve of atrial fibrillation 
(AF) free survival according to development of post-
operative atrial fibrillation (POAF) during long-term fol-
low up. The POAF group showed a significantly lower 
cumulative AF free survival than the no POAF group 
(p < 0.01).
Atrial fibrillation free survival and predictors 
of late occurrence of atrial fibrillation
Figure 2 shows AF free survival according to 
development of POAF during long-term follow up. 
The POAF group showed a significantly lower cu-
mulative AF free survival than the no POAF group 
(p < 0.01) and the POAF group curve demonstrates 
a steeper curve and continuous divergence of 
gradient suggesting ongoing risk of AF apart from 
traditional risk factors during long-term follow up.
A multivariable logistic regression was per-
formed for analysis of independent predictors 
for developing late AF. In multivariate analysis, 
E/e’ ratio (HR 1.04, 95% CI 1.00–1.08, p = 0.04) 
was an independent predictor of late occurrence 
of AF and an episode of POAF (HR 27.12, 95% 
CI 8.46–86.96, p < 0.01) was the most powerful 
predictor (Table 3).
Discussion
This study demonstrates that POAF is sig-
nificantly associated with an increased risk of late 
AF occurrence and POAF gives ongoing risk of 
developing late AF during long-term follow up. In 
addition, E/e’ ratio reflecting high LV end-diastolic 
pressure at the time of surgery was an independ-
ent predictor for developing late AF. Concomitant 
mitral valvular surgery caused independent risk 
for developing POAF, however, it was not a risk 
factor for late AF. 
Although short-term complications and out-
comes of POAF are well known, late recurrence 
rate of AF during long-term follow up in patients 
with POAF receiving OHS has not yet been es-
tablished. Recent studies have suggested that 
POAF following CABG carries a risk of future 
AF recurrence compared to patients without an 
episode of POAF [5, 6]. One study reported that 
25.4% of POAF patients with no history of AF 
who underwent primary coronary bypass surgery 
had late AF compared with 3.6% of patients with 
no POAF at median follow-up of 6 years [12]. In 
another study, a higher incidence of late AF oc-
currence was observed in the POAF group than in 
the no POAF group (18.9% vs. 2.2%, p < 0.001) 
during the follow up period of 41 ± 23 months [6]. 
Results of our study were consistent with those 
of previous studies reporting that POAF carries 
higher risk for late recurrence of AF. In multivariate 
analysis, it was found that 29.0% of POAF patients 
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developed any type of AF during long-term follow 
up, with an adjusted risk ratio of 27.1 for late AF 
compared with no POAF patients. Interestingly, 
this relative risk persisted during long-term follow 
up. This study is unique in the following points: 
first, despite previous studies which confined their 
analysis to patients undergoing isolated CABG 
surgery, this is the first study evaluating long-term 
consequences of POAF among patients undergo-
ing general OHS. In comparing the risk of POAF 
and late AF according to the type of surgery, it 
was found that more complex procedures such as 
combined surgery with valvular operation caused 
significantly higher rates of POAF rather than 
isolated CABG. However, the type of surgery was 
not an independent predictor of late AF occurrence. 
This can be explained that type and complexity of 
surgery may influence the degree of inflammation 
and alteration of hemodynamic status which can 
induce AF during post-operative period, however, 
type of surgery rarely affects development of AF 
after recovery of post-operative condition and cor-
rection of pre-operative disease. Similarly, OPCAB 
did not affect the incidence of POAF as previously 
reported [13] and we found that the development 
of late AF was not related with OPCAB. Second, 
among the research to date, the present study 
evaluated the occurrence of late AF for the longest 
follow up period (mean follow up period of 78.1 ± 
39.1 months). 
Diastolic dysfunction is associated with pro-
gressive LA enlargement and stretching of pul-
monary veins due to LA pressure overload which 
may cause arrhythmogenic activity [14]. The 
association between AF and diastolic dysfunction 
has been previously reported and diastolic dysfunc-
tion was a predictor of new onset AF [15, 16]. The 
septal E/e’ ratio, a diastolic parameter, is an easy 
and non-invasive echocardiographic marker of LV 
filling pressure. The septal E/e’ ratio ≥ 11 is an 
index of elevated LV filling pressure (> 15 mm Hg) 
with a sensitivity of 75% and a specificity of 93% 
and reflects higher LA pressure [17]. Elevated 
E/e’ ratio served as a predictor of recurrence after 
catheter ablation of AF [18] and an independent 
predictor of AF recurrence after cardioversion [19]. 
Septal E/e’ ratio was also an independent predictor 
of mortality in patients with non-valvular AF [20].
Patients with either POAF or late AF were 
significantly older than those without POAF or late 
AF. Advanced age is the most consistent predictor 
for the development of POAF [21]. Age related 
degenerative and inflammatory modifications in 
atrial anatomy and altered electrophysiological 
properties are preconditions for POAF with acute 
surgical trauma and inflammation likely providing 
the inciting factors for POAF [22, 23]. However, 
advanced age was not an independent predictor 
for developing late AF in this study, suggesting 
ongoing risk of AF in POAF patients apart from 
traditional risk factors during long-term follow up.
The findings of this study suggest that POAF 
is not a benign condition and that they can lead to a 
high incidence of future AF during long-term follow 
up, and POAF can be regarded as a risk marker for 
development of late AF. A previous study reported 
an association of POAF with decreased long-term 
survival independent of co-existing cardiovascular 
disease and comorbidities [24] and the presented 
results provide evidence supporting low probability 
of long-term survival in patients with POAF. POAF 
was the most powerful predictor of late occurrence 
Table 3. Predictors for occurrence of late atrial fibrillation (AF) during long-term follow up;  
multivariable analysis.
“No late AF” as  
a reference  
population
Univariate analysis Multivariate analysis
Hazard ratio (95% CI) P Hazard ratio (95% CI) P
Age 1.04 (1.02–1.06) < 0.01‡ 1.02 (0.97–1.07) 0.56
CHF 1.67 (0.99–2.81) 0.05 0.71 (0.21–2.45) 0.59
CKD 1.93 (1.12–3.34) 0.02* 2.54 (0.75–8.60) 0.14
LA volume 1.01 (1.00–1.02) 0.03* 1.01 (0.99–1.08) 0.08
E/e’ 1.05 (1.03–1.08) < 0.01‡ 1.04 (1.00–1.08) 0.04*
Mitral valve surgery 2.23 (1.30–3.83) < 0.01‡ 0.53 (0.14–1.95) 0.34
Post-operative AF 10.25 (6.33–16.60) < 0.01‡ 27.12 (8.46–86.96) < 0.01‡
*p < 0.05, ‡p < 0.01; CI — confidence interval; CHF — congestive heart failure; CKD — chronic kidney disease; LA — left atrial
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of AF and septal E/e’ ratio was found to be another 
predictor of late AF occurrence. 
A previously higher SYNTAX score [25] and 
HATCH score [26] were independent predictors 
for developing POAF after CABG. Vitamin D defi-
ciency was evaluated to predict the development of 
POAF in patients receiving CABG, which showed 
insignificant factor [27]. Whether these parameters 
have predictive value in the development of late 
AF were not evaluated yet and further studies 
are necessary. Although several pharmacologic or 
non-pharmacologic interventions have been shown 
to reduce the incidence of POAF [21], whether or 
not these interventions translate to a significant 
reduction of peri-operative complications and 
further reduce the incidence of late AF is still 
controversial. Future studies are required about 
strategy for prevention of late AF development in 
patients with POAF. 
Limitations of the study
There are several limitations in the present 
study. This is a retrospective investigation and 
asymptomatic AF occurrence might have been 
missed in some patients during follow up. Twelve-
lead surface ECG and 24-h or 48-h Holter moni-
toring might have limitations in patients with par-
oxysmal AF episodes. Serial evaluation of hsCRP 
concentration was not performed, therefore, the 
possibility of a relationship between CRP level 
and POAF cannot be fully excluded [28]. Because 
of heterogeneity of operation type, detailed analy-
sis of peri-operative data was difficult. Excluding 
patients with insufficient follow up can be regarded 
as a selection bias. 
Conclusions
Post-operative atrial fibrillation is significantly 
associated with an increased risk of late AF recur-
rence during long-term follow up. Careful concern 
regarding late recurrence of AF with serial evalu-
ation of rhythm status is required in patients with 
peri-operative atrial fibrillation. 
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